logo
Plus   Neg
Share
Email

CVS Health Initiates Clinical Trial For New Home Hemodialysis Device

CVS Health (CVS) said that it has initiated a clinical trial designed to evaluate the safety and efficacy of the HemoCare Hemodialysis System for administration of home hemodialysis. The device includes safety features and is designed to make home hemodialysis simple for patients. It represents next step in company-wide strategy to help improve kidney disease diagnosis and management.

Home hemodialysis helps facilitate longer, more frequent dialysis treatments as compared to in-center treatments.

Currently, hemodialysis, which uses a machine to clean a patient's blood, is most commonly administered in a dialysis center three times per week. However, an expanding body of scientific literature indicated that clinical outcomes for hemodialysis patients can be improved if treatments are longer in duration, which can be challenging to achieve via in-center dialysis.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Google announced a batch of renewable energy deals totaling 1.6 GW through 18 acquisitions spread across three continents. The deals are intended to "spur the construction of more than $2 billion in new energy infrastructure," the company said. Google said the deals will increase its worldwide portfolio... Beyond Meat's main competitor Impossible Foods will launch its grocery store in California on Friday. Beyond Meat Inc. (BYND), the meatless burger and sausage maker, announced the appointment of Sanjay Shah as Chief Operating Officer. Shah will assume the responsibility for Beyond Meat's global operations and production, effective September 18.
Follow RTT
>